{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:40:22Z","timestamp":1792633222708,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ghir.2026.101730","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:01:00Z","timestamp":1791907260000},"page":"101730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An assessment of the global usability of quality-of-life questionnaires in children receiving recombinant growth hormone therapy"],"prefix":"10.1016","volume":"85","author":[{"given":"A.","family":"Kapczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alimussina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Biersmasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Grieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"H\u00f8jby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koltowska-Haggstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maghnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Maniatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Quitmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-5549","authenticated-orcid":false,"given":"S.F.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2026.101730_bb0005","series-title":"Recommendations | Human Growth Hormone (Somatropin) for the Treatment of Growth Failure in Children | Guidance","year":"2010"},{"key":"10.1016\/j.ghir.2026.101730_bb0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00019053-200422080-00003","article-title":"Growth hormone therapy and quality of life in adults and children","volume":"22","author":"Radcliffe","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ghir.2026.101730_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/bjaed\/mkw060","article-title":"Patient-reported outcome measures and patient-reported experience measures","volume":"17","author":"Kingsley","year":"2017","journal-title":"BJA Educ."},{"issue":"1","key":"10.1016\/j.ghir.2026.101730_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s41687-023-00563-1","article-title":"Factors affecting implementation of patient-reported outcome and experience measures in a pediatric health system","volume":"7","author":"McCabe","year":"2023","journal-title":"J. Patient Rep. Outcomes"},{"issue":"1","key":"10.1016\/j.ghir.2026.101730_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-024-02706-x","article-title":"Routine use of patient-reported experience and outcome measures for children and young people: a scoping review","volume":"13","author":"Alarilla","year":"2024","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ghir.2026.101730_bb0030","series-title":"Key Considerations for Patient-Reported Outcome Measures - Petrie-Flom Center [Internet]","author":"Tribe","year":"2023"},{"key":"10.1016\/j.ghir.2026.101730_bb0035","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1210\/clinem\/dgaf500","article-title":"Trends in reported outcomes for growth hormone therapy in children with growth hormone deficiency","volume":"111","author":"Tseretopoulou","year":"2026","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101730_bb0040","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41562-025-02138-0","article-title":"Defragmenting psychology","volume":"9","author":"Anvari","year":"2025","journal-title":"Nat. Hum. Behav."},{"key":"10.1016\/j.ghir.2026.101730_bb0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12020-024-03938-6","article-title":"A comprehensive systematic review of health-related quality of life measures in short stature paediatric patients","volume":"86","author":"Adedeji","year":"2024","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ghir.2026.101730_bb0050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/cen.15298","article-title":"Development of a minimum dataset for the global monitoring of the safety and efficacy of growth hormone replacement in adults with growth hormone deficiency (AGHD)","volume":"103","author":"Chen","year":"2025","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101730_bb0060","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.healthpol.2021.07.001","article-title":"Facilitators and barriers for implementing patient-reported outcome measures in clinical care: an academic center's initial experience","volume":"125","author":"Amini","year":"2021","journal-title":"Health Policy"},{"key":"10.1016\/j.ghir.2026.101730_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","article-title":"Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force","volume":"16","author":"Matza","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.ghir.2026.101730_bb0055","series-title":"Supplementary Table 1, Supplementary Table 2","author":"Kapczuk","year":"2026"},{"key":"10.1016\/j.ghir.2026.101730_bb0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2648.2007.04333.x","article-title":"Adequacy of health-related quality of life measures in children under 5\u202fyears old: systematic review","volume":"59","author":"Grange","year":"2007","journal-title":"J. Adv. Nurs. [Internet]"},{"key":"10.1016\/j.ghir.2026.101730_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2025-003435","article-title":"Why health services should use generic PROMs and PREMs","volume":"14","author":"Benson","year":"2025","journal-title":"BMJ Open Qual."},{"key":"10.1016\/j.ghir.2026.101730_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","article-title":"Patient reported outcome measures in rare diseases: a narrative review","volume":"13","author":"Slade","year":"2018","journal-title":"Orphanet J. Rare Dis. [Internet]"},{"key":"10.1016\/j.ghir.2026.101730_bb0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40271-020-00493-w","article-title":"The use of patient-reported outcome measures in rare diseases and implications for health technology assessment","volume":"14","author":"Whittal","year":"2021","journal-title":"The Patient"},{"key":"10.1016\/j.ghir.2026.101730_bb0090","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s11136-020-02564-9","article-title":"Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings","volume":"30","author":"Stover","year":"2020","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ghir.2026.101730_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12955-018-0857-3","article-title":"Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement","volume":"16","author":"Dakin","year":"2018","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ghir.2026.101730_bb0100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1210\/clinem\/dgab874","article-title":"State of the art of patient-reported outcomes in acromegaly or GH deficiency: a systematic review and meta-analysis","volume":"107","author":"van der Meulen","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101730_bb0105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11136-012-0252-1","article-title":"Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards","volume":"22","author":"Brundage","year":"2012","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.ghir.2026.101730_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s41687-022-00466-7","article-title":"Systematic review of guidance for the collection and use of patient-reported outcomes in real-world evidence generation to support regulation, reimbursement and health policy","volume":"6","author":"Maruszczyk","year":"2022","journal-title":"J. Patient Rep. Outcomes"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:12:10Z","timestamp":1792631530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637426000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":22,"alternative-id":["S1096637426000523"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101730","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An assessment of the global usability of quality-of-life questionnaires in children receiving recombinant growth hormone therapy","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101730"}}